A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

Many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously believed, revealed a recent study....

medlinkHeart disease/medlink and medlinkcancer/medlink are the two leading causes of death in the United States. Patients with late-stage or...

THURSDAY, Jan. 9, 2025 -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging,...

THURSDAY, Jan. 9, 2025 -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging,...

WILMINGTON, Del.-- January 17, 2025 -- Datroway (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with...

WILMINGTON, Del.-- January 17, 2025 -- Datroway (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with...

New research shows that cellular architecture can predict how kidney cancer patients will respond to treatment, offering potential for more...

Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is...